Financial Advisors Network’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,257
Closed -$284K 207
2025
Q4
$284K Sell
5,257
-14
-0.3% -$674 0.04% 160
2025
Q3
$238K Buy
5,271
+230
+5% +$10.7K 0.03% 176
2025
Q2
$233K Buy
5,041
+359
+8% +$17.6K 0.04% 173
2025
Q1
$286K Sell
4,682
-1,810
-28% -$106K 0.05% 149
2024
Q4
$367K Buy
+6,492
New +$363K 0.06% 131
2023
Q4
$234K Buy
4,554
+254
+6% +$13.3K 0.05% 159
2023
Q3
$250K Buy
+4,300
New +$263K 0.06% 133
2022
Q1
Sell
-11,705
Closed -$730K 132
2021
Q4
$730K Sell
11,705
-713
-6% -$41.8K 0.16% 61
2021
Q3
$738K Buy
12,418
+1,147
+10% +$75.5K 0.17% 63
2021
Q2
$753K Buy
11,271
+267
+2% +$17.4K 0.22% 59
2021
Q1
$695K Buy
11,004
+6,288
+133% +$391K 0.22% 60
2020
Q4
$293K Sell
4,716
-127
-3% -$7.81K 0.1% 91
2020
Q3
$292K Sell
4,843
-660
-12% -$39.7K 0.11% 89
2020
Q2
$324K Sell
5,503
-1,160
-17% -$69.4K 0.13% 84
2020
Q1
$371K Buy
+6,663
New +$407K 0.18% 73
2019
Q1
Sell
-4,321
Closed -$225K 100
2018
Q4
$225K Buy
+4,321
New +$232K 0.14% 85
2017
Q1
Sell
-282
Closed -$13.5K 137
2016
Q4
$13.5K Buy
+282
New +$15.4K 0.01% 229

Other funds holding BMY

Financial Advisors Network's BMY Position: Q1 2026 in Review

Financial Advisors Network sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,257 shares — an estimated $284K sold.

Financial Advisors Network first reported a position in BMY in Q4 2016 and held it in 17 quarters. The position peaked at $753K in Q2 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Financial Advisors Network reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Financial Advisors Network sold 5,257 Bristol-Myers Squibb shares in Q1 2026, an estimated $284K.
  • Financial Advisors Network first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 17 quarters.
  • Financial Advisors Network's Bristol-Myers Squibb position peaked at $753K in Q2 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Financial Advisors Network's 13F filing for Q1 2026, filed 15 May 2026.